HIV-1 gp41 Fusion Intermediate: A Target for HIV Therapeutics
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference87 articles.
1. HIV-1 at age 25: some thoughts for Taiwan and China;Huang;J Formos Med Assoc,2008
2. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS);Barre-Sinoussi;Science,1983
3. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS;Gallo;Science,1984
4. Antiviral drugs in current clinical use;De Clercq;J Clin Virol,2004
5. Drug resistance mutations in HIV-1;Johnson;Top HIV Med,2003
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Glycan-Modified Peptides for Dual Inhibition of Human Immunodeficiency Virus Entry into Dendritic Cells and T Cells;Journal of Medicinal Chemistry;2024-02-16
2. Monocyte–Macrophage Lineage Cell Fusion;International Journal of Molecular Sciences;2022-06-12
3. Design of artificial α-helical peptides targeting both gp41 deep pocket and subpocket as potent HIV-1 fusion inhibitors;European Journal of Medicinal Chemistry;2022-06
4. Host cell membrane microdomains and fungal infection;Cellular Microbiology;2021-08-24
5. A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity;Journal of Virology;2021-07-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3